Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

Obesity paradox in cancer: new insights provided by body composition

(2014) Maria Cristina Gonzalez et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia

(2014) Serkan Kir et al.   NATURE

Change of Body Weight and Macrophage Inhibitory Cytokine-1 during Chemotherapy in Advanced Gastric Cancer: What Is Their Clinical Significance?

(2014) Zhihao Lu et al.   PLoS One

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer

(2013) C Pezaro et al.   BRITISH JOURNAL OF CANCER

Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer

(2013) Pasquale F. Innominato et al.   CANCER

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis

(2013)   EUROPEAN JOURNAL OF CANCER

The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy

(2013) Younak Choi et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy

(2012) Karla Sánchez-Lara et al.   BRITISH JOURNAL OF NUTRITION

Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer

(2012) Matthew R. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis

(2012) Christine Baldwin et al.   JNCI-Journal of the National Cancer Institute

Physical Exercise for Cancer Patients with Advanced Disease: A Randomized Controlled Trial

(2011) L. M. Oldervoll et al.   ONCOLOGIST

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET